Views on Dishman Pharmaceuticals and Chemicals Ltd 1QFY2017 Results: Angel Broking

Views of Ms. Sarabjit Kour Nangra (VP- Research Pharma, Angel Broking) on Dishman Pharmaceuticals and Chemicals Ltd 1QFY2017 Results:

"For 1QFY2017, the company posted better than expected results. The sales came in at INR 366cr V/s INR 350cr expected V/s INR 400cr in 1QFY2016, a YoY de-growth of 8.5%. The CRAMS (INR 258cr), posted a YoY growth of 2.3%, other segment (INR 108cr) posted a de-growth of 26.9%. On the operating profit front, the EBITDA margins came in at 25.3% V/s 20.9% expected v/s 25.4% in 1QFY2016. Thus, the Adj. net profit came in at INR 45.5cr V/s INR 32cr expected and INR 41cr in 1QFY2016, a YoY growth of 13.7%. Our rating is under review."

Shares of DISHMAN PHARMACEUTICALS & CHEMICALS LTD. was last trading in BSE at Rs.170.3 as compared to the previous close of Rs. 175.9. The total number of shares traded during the day was 494744 in over 5844 trades.

The stock hit an intraday high of Rs. 177.4 and intraday low of 169.55. The net turnover during the day was Rs. 85523221.

Source : Equity Bulls

Keywords